Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

April 01, 1996; Volume 49,Issue 4
  • You have access
    Pharmacological discrimination of GluR5 and GluR6 kainate receptor subtypes by (3S,4aR,6R,8aR)-6-[2-(1(2)H-tetrazole-5-yl)ethyl]decahyd roisdoquinoline-3 carboxylic-acid.
    R Bleakman, D D Schoepp, B Ballyk, H Bufton, E F Sharpe, K Thomas, P L Ornstein and R K Kamboj
    Molecular Pharmacology April 1996, 49 (4) 581-585;
  • You have access
    Metabotropic and ionotropic transducers of glutamate signal inversely control cytoplasmic Ca2+ concentration and excitotoxicity in cultured cerebellar granule cells: pivotal role of protein kinase C.
    M Pizzi, P Galli, O Consolandi, V Arrighi, M Memo and P F Spano
    Molecular Pharmacology April 1996, 49 (4) 586-594;
  • You have access
    Separation of resistance to antitumor diarylsulfonylurea agents from collateral sensitivity to mitochondrial toxins.
    L L Shu and P J Houghton
    Molecular Pharmacology April 1996, 49 (4) 595-601;
  • You have access
    Suramin analogues as subtype-selective G protein inhibitors.
    M Freissmuth, S Boehm, W Beindl, P Nickel, A P Ijzerman, M Hohenegger and C Nanoff
    Molecular Pharmacology April 1996, 49 (4) 602-611;
  • You have access
    Modulation of glucocorticoid-inducible gene expression by metal ions.
    Y Makino, H Tanaka, K Dahlman-Wright and I Makino
    Molecular Pharmacology April 1996, 49 (4) 612-620;
  • You have access
    Effects of nucleotide analogues on human immunodeficiency virus type 1 integrase.
    A Mazumder, N Neamati, J P Sommadossi, G Gosselin, R F Schinazi, J L Imbach and Y Pommier
    Molecular Pharmacology April 1996, 49 (4) 621-628;
  • You have access
    Beta-Adrenoceptor-medicated down-regulation of M2 muscarinic receptors: role of cyclic adenosine 5'-monophosphate-dependent protein kinase and protein kinase C.
    J Rousell, E B Haddad, J C Mak, B L Webb, M A Giembycz and P J Barnes
    Molecular Pharmacology April 1996, 49 (4) 629-635;
  • You have access
    Induction of chronic Fos-related antigens in rat brain by chronic morphine administration.
    H E Nye and E J Nestler
    Molecular Pharmacology April 1996, 49 (4) 636-645;
  • You have access
    Thyrotropin-releasing hormone-induced subcellular redistribution and down-regulation of G11alpha: analysis of agonist regulation of coexpressed G11alpha species variants.
    P Svoboda, G D Kim, M A Grassie, K A Eidne and G Milligan
    Molecular Pharmacology April 1996, 49 (4) 646-655;
  • You have access
    D2, D3, and D4 dopamine receptors couple to G protein-regulated potassium channels in Xenopus oocytes.
    P Werner, N Hussy, G Buell, K A Jones and R A North
    Molecular Pharmacology April 1996, 49 (4) 656-661;
  • You have access
    Modulation of the inwardly rectifying potassium channel IRK1 by the m1 muscarinic receptor.
    S V Jones
    Molecular Pharmacology April 1996, 49 (4) 662-667;
  • You have access
    Coupling of I1-imidazoline receptors to diacylglyceride accumulation in PC12 rat pheochromocytoma cells.
    D Separovic, M Kester and P Ernsberger
    Molecular Pharmacology April 1996, 49 (4) 668-675;
  • You have access
    Isolation of N-vinylprotoporphyrin IX after hepatic cytochrome P450 inactivation by 3-[(arylthio)ethyl]sydnone in chick embryos pretreated with phenobarbital, glutethimide, dexamethasone, and beta-naphthoflavone: differential inhibition of ferrochelatase by N-vinylprotoporphyrin regioisomers.
    S M Kimmett, R A Whitney and G S Marks
    Molecular Pharmacology April 1996, 49 (4) 676-682;
  • You have access
    Glutamate residues in the second extracellular loop of the human A2a adenosine receptor are required for ligand recognition.
    J Kim, Q Jiang, M Glashofer, S Yehle, J Wess and K A Jacobson
    Molecular Pharmacology April 1996, 49 (4) 683-691;
  • You have access
    Differentiating dopamine D2 ligands by their sensitivities to modification of the cysteine exposed in the binding-site crevice.
    J A Javitch, D Fu and J Chen
    Molecular Pharmacology April 1996, 49 (4) 692-698;
  • You have access
    Cyclic AMP-dependent regulation of fibroblast growth factor-2 messenger RNA levels in rat cortical astrocytes: comparison with fibroblast growth factor-1 and ciliary neurotrophic factor.
    M A Riva, R Molteni, E Lovati, F Fumagalli, M Rusnati and G Racagni
    Molecular Pharmacology April 1996, 49 (4) 699-706;
  • You have access
    Rat brain cannabinoid receptor modulates N-type Ca2+ channels in a neuronal expression system.
    X Pan, S R Ikeda and D L Lewis
    Molecular Pharmacology April 1996, 49 (4) 707-714;
  • You have access
    Ciclazindol inhibits ATP-sensitive K+ channels and stimulates insulin secretion in CR1-G1 insulin-secreting cells.
    K Lee, R N Khan, I C Rowe, S E Ozanne, A C Hall, E Papadakis, C N Hales and M L Ashford
    Molecular Pharmacology April 1996, 49 (4) 715-720;
  • You have access
    Activities of novel nonglycosidic epipodophyllotoxins in etoposide-sensitive and -resistant variants of human KB cells, P-388 cells, and in vivo multidrug-resistant murine leukemia cells.
    I O Anyanwutaku, X Guo, H X Chen, Z Ji, K H Lee and Y C Cheng
    Molecular Pharmacology April 1996, 49 (4) 721-726;
  • You have access
    Unusual steroid specificity of the cell surface progesterone receptor on human sperm.
    P F Blackmore, J F Fisher, C H Spilman and J E Bleasdale
    Molecular Pharmacology April 1996, 49 (4) 727-739;
  • You have access
    Ortho-substituted polychlorinated biphenyls alter calcium regulation by a ryanodine receptor-mediated mechanism: structural specificity toward skeletal- and cardiac-type microsomal calcium release channels.
    P W Wong and I N Pessah
    Molecular Pharmacology April 1996, 49 (4) 740-751;
  • You have access
    Distinct receptor domains determine subtype-specific coupling and desensitization phenotypes for human beta1- and beta2-adrenergic receptors.
    G Rousseau, F Nantel and M Bouvier
    Molecular Pharmacology April 1996, 49 (4) 752-760;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 49, Issue 4
1 Apr 1996
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics